In 2024, hospital discharges for malignant neoplasm of the prostate in Switzerland are forecasted to reach 202.7 discharges per hundred thousand persons. This number is projected to steadily increase, reaching 206.4 discharges per hundred thousand by 2028. Comparing the actual data from 2023, where the number stood at 201.6 discharges per hundred thousand persons, we observe a slight upward trend.
Year-on-year variations:
- 2024 vs. 2023: +0.5%
- 2025 vs. 2024: +0.6%
- 2026 vs. 2025: +0.5%
- 2027 vs. 2026: +0.4%
- 2028 vs. 2027: +0.3%
Over the last two years (2023-2025), the average annual growth rate is approximately 0.55%. The compound annual growth rate (CAGR) over the five years (2023-2028) stands at roughly 0.46% per year.
Future trends to watch for include advances in medical treatments and early detection methods, which could affect the hospitalization rates. Additionally, demographic changes such as aging population may continue to influence the trend over the coming years.
